Previous 10 | Next 10 |
2023-07-25 03:48:12 ET Summary Danaher is an industry-leading serial acquirer with an iconic business system. After a boom in Danaher's sales during the pandemic, demand is now slowing as customers are facing inventory build-up and liquidity challenges. Beyond the current head...
2023-07-25 01:55:00 ET Summary S&P 500 EPS growth for Q2 2023 is set to come in at -9%, the lowest rate in 3 years and the third consecutive quarter of negative earnings growth. The LERI shows corporate uncertainty remains at its highest level since the pandemic. Potential...
2023-07-24 12:22:29 ET Danaher ( NYSE: DHR ) is scheduled to announce Q2 earnings results on Tuesday, July 25th, before market open. The consensus EPS Estimate is $2.02 (-26.8% Y/Y) and the consensus Revenue Estimate is $7.12B (-8.1% Y/Y). Over the last 2 years, DHR ...
2023-07-23 07:50:02 ET Summary A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. Introduction The D...
2023-07-21 11:43:42 ET Sartorius AG ( OTCPK:SARTF ) traded sharply higher on Friday, rallying the shares of its U.S. peers, after the German life sciences company posted its Q2 2023 results, indicating a gradual recovery following a post-pandemic contraction in demand. Notable gaine...
2023-07-20 01:00:00 ET Summary In the second quarter, the top five contributors to performance were Alphabet, Copart, Alcon, Parker-Hannifin, and PACCAR. Analog Devices and Danaher are both seeing end market demand moderate compared to the artificially high levels they experienced...
2023-07-19 22:37:19 ET Catalent ( NYSE: CTLT ) rose 8.8% in after hours trading after a report that activist investor Elliott Investment Management has taken a significant stake in the contract drug manufacturer. Elliott is pushing for changes in the company's board and has ...
Beckman Coulter and Fujirebio Partner to Bolster Access to Patient-friendly, Blood-based Alzheimer's Disease Test PR Newswire Collaboration Builds upon Fujirebio Expertise in Neurodegenerative Disease Assays and Beckman Coulter's High Sensitivity, High Throughput, Global...
2023-07-14 09:15:00 ET Summary Distillate Capital Partners LLC was formed in 2017 and is based in Chicago, IL. The firm is 100% employee-owned, and DCP’s partners each have invested significantly in the firm’s investment strategies. A strong rally moved market levels...
2023-07-14 03:55:03 ET Summary My passive income for June 2023 was the highest ever, with dividends up by 51.97% year-on-year, covering his mortgage and car payments. The significant dividend growth is attributed to the rapid rise in interest rates over the past 12-18 months, with...
News, Short Squeeze, Breakout and More Instantly...
2024-07-26 10:45:04 ET Pacific Biosciences of California Inc (PACB) PACB is trading UP for the last 5 days, and it at trading at $2.10 with volume of 3,952,245 and a one day change of $0.19 (9.97%). Pacific Biosciences of California Inc has a 52-week low of 1.16 and a 52-week high o...
Beckman Coulter's DxI 9000 Immunoassay Analyzer Honored at Premier, Inc.'s Annual Supplier Innovation Celebration PR Newswire BREA, Calif. , July 25, 2024 /PRNewswire/ -- Beckman Coulter Diagnostics, a clinical diagnostics leader, today announced that the Dx...
2024-07-23 20:30:03 ET Goldman Sachs analyst issues NEUTRAL recommendation for DHR on July 23, 2024 06:19PM ET. The previous analyst recommendation was Neutral. DHR was trading at $264.18 at issue of the analyst recommendation. The overall analyst consensus : BUY. Cu...